Index by author

01 February 2011; volume 37, issue 2

A

  1. Aggarwal, D.

    1. Aggarwal, D., and P.R. Mohapatra. "Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis." European Respiratory Journal 37.2 (2011): 476. Web. 17 Feb. 2019.

  2. Agusti, A.G.N.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  3. Alissafi, T.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  4. Ambrosino, N.

    1. Ambrosino, N.. "The case for inspiratory muscle training in COPD." European Respiratory Journal 37.2 (2011): 233-235. Web. 17 Feb. 2019.
    2. Ambrosino, N.. "Non-invasive Ventilation and Weaning: Principles and Practice." European Respiratory Journal 37.2 (2011): 478. Web. 17 Feb. 2019.

  5. Amrein, K.

    1. Amrein, K., G. Schilcher, and A. Fahrleitner-Pammer. "Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose." European Respiratory Journal 37.2 (2011): 470-471. Web. 17 Feb. 2019.

  6. Anderson, W.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  7. Azoulay, E.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

B

  1. Baker, J.

    1. Dogra, S. et al "Exercise is associated with improved asthma control in adults." European Respiratory Journal 37.2 (2011): 318-323. Web. 17 Feb. 2019.

  2. Bakke, P.S.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  3. Baraldi, E.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  4. Barbato, A.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  5. Bärtsch, P.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.

  6. Becker, A.B.

    1. Carlsten, C. et al "Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort." European Respiratory Journal 37.2 (2011): 324-330. Web. 17 Feb. 2019.

  7. Bindels, P.J.E.

    1. Habraken, J.M. et al "Health-related quality of life and functional status in end-stage COPD: a longitudinal study." European Respiratory Journal 37.2 (2011): 280-288. Web. 17 Feb. 2019.

  8. Boczkowski, J.

    1. Lanone, S., and J. Boczkowski. "Titanium and gold nanoparticles in asthma: the bad and the ugly." European Respiratory Journal 37.2 (2011): 225-227. Web. 17 Feb. 2019.

  9. Boland, S.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  10. Bossios, A.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  11. Brauer, M.

    1. Carlsten, C. et al "Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort." European Respiratory Journal 37.2 (2011): 324-330. Web. 17 Feb. 2019.

  12. Bush, A.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

C

  1. Calverley, P.M.A.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  2. Carlsen, K.H.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  3. Carlsten, C.

    1. Carlsten, C. et al "Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort." European Respiratory Journal 37.2 (2011): 324-330. Web. 17 Feb. 2019.

  4. Cazzola, M.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

  5. Centanni, S.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

  6. Chan-Yeung, M.

    1. Carlsten, C. et al "Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort." European Respiratory Journal 37.2 (2011): 324-330. Web. 17 Feb. 2019.

  7. Chaudri, A.

    1. Schuetz, P. et al "Prognostic value of procalcitonin in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 384-392. Web. 17 Feb. 2019.

  8. Chevret, S.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  9. Chida, K.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  10. Chiu, Y-C.

    1. Su, W-J. et al "Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 376-383. Web. 17 Feb. 2019.

  11. Christ-Crain, M.

    1. Schuetz, P. et al "Prognostic value of procalcitonin in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 384-392. Web. 17 Feb. 2019.

  12. Cillóniz, C.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  13. Connett, J.E.

    1. Kunisaki, K.M. et al "Vitamin D status and longitudinal lung function decline in the Lung Health Study." European Respiratory Journal 37.2 (2011): 238-243. Web. 17 Feb. 2019.

  14. Cortijo, J.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

D

  1. Dahl, R.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

  2. Dao, P.

    1. Duong-Quy, S. et al "Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function." European Respiratory Journal 37.2 (2011): 349-355. Web. 17 Feb. 2019.

  3. Darmon, M.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  4. de Benedictis, F.M.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  5. Decramer, M.

    1. Gosselink, R. et al "Impact of inspiratory muscle training in patients with COPD: what is the evidence?." European Respiratory Journal 37.2 (2011): 416-425. Web. 17 Feb. 2019.

  6. Dehnert, C.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.

  7. De Jongste, J.C.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  8. De Vooght, V.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  9. De Vos, J.

    1. Gosselink, R. et al "Impact of inspiratory muscle training in patients with COPD: what is the evidence?." European Respiratory Journal 37.2 (2011): 416-425. Web. 17 Feb. 2019.

  10. Diaz, R.

    1. Izquierdo-García, J.L. et al "Is NMR-based metabolomic analysis of exhaled breath condensate accurate?." European Respiratory Journal 37.2 (2011): 468-470. Web. 17 Feb. 2019.

  11. Dimich-Ward, H.

    1. Carlsten, C. et al "Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort." European Respiratory Journal 37.2 (2011): 324-330. Web. 17 Feb. 2019.

  12. Dinh-Xuan, A.T.

    1. Duong-Quy, S. et al "Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function." European Respiratory Journal 37.2 (2011): 349-355. Web. 17 Feb. 2019.

  13. Dinsdale, D.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  14. Dogra, A.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

  15. Dogra, S.

    1. Dogra, S. et al "Exercise is associated with improved asthma control in adults." European Respiratory Journal 37.2 (2011): 318-323. Web. 17 Feb. 2019.

  16. Donet, E.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

  17. Donner, C.F.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  18. Duong-Quy, S.

    1. Duong-Quy, S. et al "Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function." European Respiratory Journal 37.2 (2011): 349-355. Web. 17 Feb. 2019.

  19. Dybuncio, A.

    1. Carlsten, C. et al "Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort." European Respiratory Journal 37.2 (2011): 324-330. Web. 17 Feb. 2019.

E

  1. Economidou, E.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  2. Eifuku, T.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  3. Esquinas, C.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

F

  1. Fahrleitner-Pammer, A.

    1. Amrein, K., G. Schilcher, and A. Fahrleitner-Pammer. "Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose." European Respiratory Journal 37.2 (2011): 470-471. Web. 17 Feb. 2019.

  2. Fauroux, B.

    1. Lofaso, F. et al "Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography." European Respiratory Journal 37.2 (2011): 231-232. Web. 17 Feb. 2019.

  3. Feng, J-Y.

    1. Su, W-J. et al "Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 376-383. Web. 17 Feb. 2019.

  4. Ferrer, J.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  5. Filella, X.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  6. Fisher, A.J.

    1. Lee, W-T.N. et al "Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 472-474. Web. 17 Feb. 2019.

  7. Frese, F.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.

  8. Fulgencio, J-P.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

G

  1. Gaga, M.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  2. Galiè, N.

    1. Galiè, N. et al "Liver toxicity of sitaxentan in pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 475-476. Web. 17 Feb. 2019.

  3. García-Valero, J.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  4. Garrigues, B.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  5. Gavaldà, A.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

  6. Gibbs, J.S.R.

    1. Galiè, N. et al "Liver toxicity of sitaxentan in pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 475-476. Web. 17 Feb. 2019.

  7. Gogos, H.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  8. Gosselink, R.

    1. Gosselink, R. et al "Impact of inspiratory muscle training in patients with COPD: what is the evidence?." European Respiratory Journal 37.2 (2011): 416-425. Web. 17 Feb. 2019.

  9. Goto, H.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  10. Gouzes, C.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  11. Green, M.

    1. Polkey, M.I., J. Moxham, and M. Green. "The case against inspiratory muscle training in COPD." European Respiratory Journal 37.2 (2011): 236-237. Web. 17 Feb. 2019.

  12. Guilluy, C.

    1. Duong-Quy, S. et al "Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function." European Respiratory Journal 37.2 (2011): 349-355. Web. 17 Feb. 2019.

  13. Gulsvik, A.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

H

  1. Habraken, J.M.

    1. Habraken, J.M. et al "Health-related quality of life and functional status in end-stage COPD: a longitudinal study." European Respiratory Journal 37.2 (2011): 280-288. Web. 17 Feb. 2019.

  2. Hamano, E.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  3. Hayakawa, H.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  4. Hedlin, G.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  5. Heili, S.

    1. Izquierdo-García, J.L. et al "Is NMR-based metabolomic analysis of exhaled breath condensate accurate?." European Respiratory Journal 37.2 (2011): 468-470. Web. 17 Feb. 2019.

  6. Hemminki, K.

    1. Hemminki, K. et al "Subsequent COPD and lung cancer in patients with autoimmune disease." European Respiratory Journal 37.2 (2011): 463-465. Web. 17 Feb. 2019.

  7. Hoeper, M.M.

    1. Galiè, N. et al "Liver toxicity of sitaxentan in pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 475-476. Web. 17 Feb. 2019.

  8. Hoet, P.H.M.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  9. Hojo, M.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  10. Hong, S-B.

    1. Song, J.W. et al "Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome." European Respiratory Journal 37.2 (2011): 356-363. Web. 17 Feb. 2019.

  11. Hua-Huy, T.

    1. Duong-Quy, S. et al "Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function." European Respiratory Journal 37.2 (2011): 349-355. Web. 17 Feb. 2019.

  12. Huang, C-D.

    1. Liu, W-T. et al "A mobile telephone-based interactive self-care system improves asthma control." European Respiratory Journal 37.2 (2011): 310-317. Web. 17 Feb. 2019.

  13. Huang, S-F.

    1. Su, W-J. et al "Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 376-383. Web. 17 Feb. 2019.

  14. Huertas, A.

    1. Huertas, A., and P. Palange. "Circulating endothelial progenitor cells and chronic pulmonary diseases." European Respiratory Journal 37.2 (2011): 426-431. Web. 17 Feb. 2019.

  15. Hussain, S.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

I

  1. Ichiwata, T.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  2. Inoue, Y.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  3. Ishii, H.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  4. Izquierdo-García, J.L.

    1. Izquierdo-García, J.L. et al "Is NMR-based metabolomic analysis of exhaled breath condensate accurate?." European Respiratory Journal 37.2 (2011): 468-470. Web. 17 Feb. 2019.

J

  1. Jamnik, V.

    1. Dogra, S. et al "Exercise is associated with improved asthma control in adults." European Respiratory Journal 37.2 (2011): 318-323. Web. 17 Feb. 2019.

  2. Ji, J.

    1. Hemminki, K. et al "Subsequent COPD and lung cancer in patients with autoimmune disease." European Respiratory Journal 37.2 (2011): 463-465. Web. 17 Feb. 2019.

  3. Johnson, M.K.

    1. Lee, W-T.N. et al "Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 472-474. Web. 17 Feb. 2019.

  4. Johnston, N.

    1. Johnston, N., P. O'Byrne, and M. Kolb. "The promise of electronic data capture in respiratory medicine." European Respiratory Journal 37.2 (2011): 228-230. Web. 17 Feb. 2019.

  5. Jolley, C.J.

    1. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

K

  1. Kaneko, C.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  2. Kessler, R.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

  3. Kim, D.S.

    1. Song, J.W. et al "Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome." European Respiratory Journal 37.2 (2011): 356-363. Web. 17 Feb. 2019.

  4. Kirkham, N.

    1. Lee, W-T.N. et al "Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 472-474. Web. 17 Feb. 2019.

  5. Koenderman, L.

    1. Langereis, J.D. et al "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils." European Respiratory Journal 37.2 (2011): 406-415. Web. 17 Feb. 2019.

  6. Kogure, Y.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  7. Koh, Y.

    1. Song, J.W. et al "Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome." European Respiratory Journal 37.2 (2011): 356-363. Web. 17 Feb. 2019.

  8. Kolb, M.

    1. Johnston, N., P. O'Byrne, and M. Kolb. "The promise of electronic data capture in respiratory medicine." European Respiratory Journal 37.2 (2011): 228-230. Web. 17 Feb. 2019.

  9. Kong, X.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  10. Kornmann, O.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

  11. Kramer, B.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

  12. Kuk, J.L.

    1. Dogra, S. et al "Exercise is associated with improved asthma control in adults." European Respiratory Journal 37.2 (2011): 318-323. Web. 17 Feb. 2019.

  13. Kunisaki, K.M.

    1. Kunisaki, K.M. et al "Vitamin D status and longitudinal lung function decline in the Lung Health Study." European Respiratory Journal 37.2 (2011): 238-243. Web. 17 Feb. 2019.

  14. Kuo, H-P.

    1. Liu, W-T. et al "A mobile telephone-based interactive self-care system improves asthma control." European Respiratory Journal 37.2 (2011): 310-317. Web. 17 Feb. 2019.

  15. Kwakkel, G.

    1. Gosselink, R. et al "Impact of inspiratory muscle training in patients with COPD: what is the evidence?." European Respiratory Journal 37.2 (2011): 416-425. Web. 17 Feb. 2019.

L

  1. Lammers, J-W.J.

    1. Langereis, J.D. et al "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils." European Respiratory Journal 37.2 (2011): 406-415. Web. 17 Feb. 2019.

  2. Lange, C.

    1. Yew, W.W., C. Lange, and C.C. Leung. "Treatment of tuberculosis: update 2010." European Respiratory Journal 37.2 (2011): 441-462. Web. 17 Feb. 2019.

  3. Langereis, J.D.

    1. Langereis, J.D. et al "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils." European Respiratory Journal 37.2 (2011): 406-415. Web. 17 Feb. 2019.

  4. Lanone, S.

    1. Lanone, S., and J. Boczkowski. "Titanium and gold nanoparticles in asthma: the bad and the ugly." European Respiratory Journal 37.2 (2011): 225-227. Web. 17 Feb. 2019.

  5. Lassen, C.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

  6. Lee, K-Y.

    1. Liu, W-T. et al "A mobile telephone-based interactive self-care system improves asthma control." European Respiratory Journal 37.2 (2011): 310-317. Web. 17 Feb. 2019.

  7. Lee, W-T.N.

    1. Lee, W-T.N. et al "Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 472-474. Web. 17 Feb. 2019.

  8. Lee, Y-C.

    1. Su, W-J. et al "Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 376-383. Web. 17 Feb. 2019.

  9. le Gall, J-R.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  10. Leung, C.C.

    1. Yew, W.W., C. Lange, and C.C. Leung. "Treatment of tuberculosis: update 2010." European Respiratory Journal 37.2 (2011): 441-462. Web. 17 Feb. 2019.

  11. Levy, R.D.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  12. Leynaud, D.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

  13. Lim, C-M.

    1. Song, J.W. et al "Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome." European Respiratory Journal 37.2 (2011): 356-363. Web. 17 Feb. 2019.

  14. Lin, S-M.

    1. Liu, W-T. et al "A mobile telephone-based interactive self-care system improves asthma control." European Respiratory Journal 37.2 (2011): 310-317. Web. 17 Feb. 2019.

  15. Liu, W-T.

    1. Liu, W-T. et al "A mobile telephone-based interactive self-care system improves asthma control." European Respiratory Journal 37.2 (2011): 310-317. Web. 17 Feb. 2019.

  16. Liu, X.

    1. Hemminki, K. et al "Subsequent COPD and lung cancer in patients with autoimmune disease." European Respiratory Journal 37.2 (2011): 463-465. Web. 17 Feb. 2019.

  17. Lødrup Carlsen, K.C.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  18. Lofaso, F.

    1. Lofaso, F. et al "Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography." European Respiratory Journal 37.2 (2011): 231-232. Web. 17 Feb. 2019.

  19. Lomas, D.A.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  20. Lordan, J.L.

    1. Lee, W-T.N. et al "Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 472-474. Web. 17 Feb. 2019.

  21. Lötvall, J.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  22. Luo, Y.M.

    1. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

  23. Luyts, K.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

M

  1. Mairbäurl, H.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.

  2. Make, B.J.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  3. Malmström, K.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  4. Marano, F.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  5. Martens, J.A.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  6. Martínez, A.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  7. Martínez, R.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  8. Mata, M.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

  9. Menéndez, R.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  10. Middelveld, R.J.M.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  11. Milara, J.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

  12. Miralpeix, M.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

  13. Miravitlles, M.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

  14. Miwa, S.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  15. Mohapatra, P.R.

    1. Aggarwal, D., and P.R. Mohapatra. "Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis." European Respiratory Journal 37.2 (2011): 476. Web. 17 Feb. 2019.

  16. Moine, P.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  17. Montero, M.A.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  18. Montes, J.F.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  19. Morcillo, E.J.

    1. Cortijo, J. et al "Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways." European Respiratory Journal 37.2 (2011): 244-254. Web. 17 Feb. 2019.

  20. Moxham, J.

    1. Polkey, M.I., J. Moxham, and M. Green. "The case against inspiratory muscle training in COPD." European Respiratory Journal 37.2 (2011): 236-237. Web. 17 Feb. 2019.
    2. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

  21. Mueller, B.

    1. Schuetz, P. et al "Prognostic value of procalcitonin in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 384-392. Web. 17 Feb. 2019.

N

  1. Nakamura, H.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  2. Nakata, K.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  3. Nemery, B.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  4. Niewoehner, D.E.

    1. Kunisaki, K.M. et al "Vitamin D status and longitudinal lung function decline in the Lung Health Study." European Respiratory Journal 37.2 (2011): 238-243. Web. 17 Feb. 2019.

  5. Nishida, A.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  6. Nishiyama, O.

    1. Nishiyama, O., and H. Taniguchi. "From the authors:." European Respiratory Journal 37.2 (2011): 476-477. Web. 17 Feb. 2019.

O

  1. O'Byrne, P.

    1. Johnston, N., P. O'Byrne, and M. Kolb. "The promise of electronic data capture in respiratory medicine." European Respiratory Journal 37.2 (2011): 228-230. Web. 17 Feb. 2019.

  2. Ohba, H.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  3. Olloquequi, J.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  4. Orlikowski, D.

    1. Lofaso, F. et al "Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography." European Respiratory Journal 37.2 (2011): 231-232. Web. 17 Feb. 2019.

  5. Ostinelli, J.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

  6. Oudijk, E-J.D.

    1. Langereis, J.D. et al "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils." European Respiratory Journal 37.2 (2011): 406-415. Web. 17 Feb. 2019.

  7. Owen, R.

    1. Kornmann, O. et al "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison." European Respiratory Journal 37.2 (2011): 273-279. Web. 17 Feb. 2019.

P

  1. Pacaud, P.

    1. Duong-Quy, S. et al "Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function." European Respiratory Journal 37.2 (2011): 349-355. Web. 17 Feb. 2019.

  2. Palange, P.

    1. Huertas, A., and P. Palange. "Circulating endothelial progenitor cells and chronic pulmonary diseases." European Respiratory Journal 37.2 (2011): 426-431. Web. 17 Feb. 2019.

  3. Panoutsakopoulou, V.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  4. Paré, P.D.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  5. Partridge, M.R.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

  6. Peacock, A.J.

    1. Lee, W-T.N. et al "Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 472-474. Web. 17 Feb. 2019.

  7. Peces-Barba, G.

    1. Izquierdo-García, J.L. et al "Is NMR-based metabolomic analysis of exhaled breath condensate accurate?." European Respiratory Journal 37.2 (2011): 468-470. Web. 17 Feb. 2019.

  8. Pedersen, S.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  9. Pedroletti, C.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  10. Piacentini, G.L.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  11. Pillai, S.G.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  12. Pohunek, P.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  13. Polkey, M.I.

    1. Polkey, M.I., J. Moxham, and M. Green. "The case against inspiratory muscle training in COPD." European Respiratory Journal 37.2 (2011): 236-237. Web. 17 Feb. 2019.
    2. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

  14. Polverino, E.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  15. Prats, A.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  16. Prigent, H.

    1. Lofaso, F. et al "Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography." European Respiratory Journal 37.2 (2011): 231-232. Web. 17 Feb. 2019.

R

  1. Ramírez, P.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  2. Rennard, S.I.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  3. Reyes, S.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  4. Rodríguez, E.

    1. Olloquequi, J. et al "Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients." European Respiratory Journal 37.2 (2011): 289-298. Web. 17 Feb. 2019.

  5. Ruiz-Cabello, J.

    1. Izquierdo-García, J.L. et al "Is NMR-based metabolomic analysis of exhaled breath condensate accurate?." European Respiratory Journal 37.2 (2011): 468-470. Web. 17 Feb. 2019.

S

  1. Samitas, K.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  2. Saraya, T.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  3. Schilcher, G.

    1. Amrein, K., G. Schilcher, and A. Fahrleitner-Pammer. "Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose." European Respiratory Journal 37.2 (2011): 470-471. Web. 17 Feb. 2019.

  4. Schmitt, L.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.

  5. Schuetz, P.

    1. Schuetz, P. et al "Prognostic value of procalcitonin in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 384-392. Web. 17 Feb. 2019.

  6. Schweizer, R.C.

    1. Langereis, J.D. et al "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils." European Respiratory Journal 37.2 (2011): 406-415. Web. 17 Feb. 2019.

  7. Segers, J.

    1. Gosselink, R. et al "Impact of inspiratory muscle training in patients with COPD: what is the evidence?." European Respiratory Journal 37.2 (2011): 416-425. Web. 17 Feb. 2019.

  8. Semitekolou, M.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  9. Seymour, J.

    1. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

  10. Shirai, M.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  11. Silverman, E.K.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  12. Simonneau, G.

    1. Galiè, N. et al "Liver toxicity of sitaxentan in pulmonary arterial hypertension." European Respiratory Journal 37.2 (2011): 475-476. Web. 17 Feb. 2019.

  13. Singh, R.J.

    1. Kunisaki, K.M. et al "Vitamin D status and longitudinal lung function decline in the Lung Health Study." European Respiratory Journal 37.2 (2011): 238-243. Web. 17 Feb. 2019.

  14. Song, J.W.

    1. Song, J.W. et al "Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome." European Respiratory Journal 37.2 (2011): 356-363. Web. 17 Feb. 2019.

  15. Steier, J.

    1. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

  16. Su, W-J.

    1. Su, W-J. et al "Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 376-383. Web. 17 Feb. 2019.

  17. Suda, T.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  18. Sundquist, J.

    1. Hemminki, K. et al "Subsequent COPD and lung cancer in patients with autoimmune disease." European Respiratory Journal 37.2 (2011): 463-465. Web. 17 Feb. 2019.

  19. Sundquist, K.

    1. Hemminki, K. et al "Subsequent COPD and lung cancer in patients with autoimmune disease." European Respiratory Journal 37.2 (2011): 463-465. Web. 17 Feb. 2019.

  20. Suter-Widmer, I.

    1. Schuetz, P. et al "Prognostic value of procalcitonin in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 384-392. Web. 17 Feb. 2019.

T

  1. Takada, T.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  2. Taniguchi, H.

    1. Nishiyama, O., and H. Taniguchi. "From the authors:." European Respiratory Journal 37.2 (2011): 476-477. Web. 17 Feb. 2019.

  3. Tazawa, R.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  4. Teboul, V.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  5. Terada, M.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  6. ter Riet, G.

    1. Habraken, J.M. et al "Health-related quality of life and functional status in end-stage COPD: a longitudinal study." European Respiratory Journal 37.2 (2011): 280-288. Web. 17 Feb. 2019.

  7. Teschler, H.

    1. Steier, J. et al "Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis." European Respiratory Journal 37.2 (2011): 400-405. Web. 17 Feb. 2019.

  8. Thomassen, L.C.J.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  9. Toben, F.

    1. Habraken, J.M. et al "Health-related quality of life and functional status in end-stage COPD: a longitudinal study." European Respiratory Journal 37.2 (2011): 280-288. Web. 17 Feb. 2019.

  10. Tomii, K.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

  11. Torres, A.

    1. Martínez, R. et al "Factors associated with inflammatory cytokine patterns in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 393-399. Web. 17 Feb. 2019.

  12. Trapnell, B.C.

    1. Ishii, H. et al "Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan." European Respiratory Journal 37.2 (2011): 465-468. Web. 17 Feb. 2019.

U

  1. Ugajin, M.

    1. Ugajin, M. et al "Usefulness of serum procalcitonin levels in pulmonary tuberculosis." European Respiratory Journal 37.2 (2011): 371-375. Web. 17 Feb. 2019.

  2. Ulfman, L.H.

    1. Langereis, J.D. et al "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils." European Respiratory Journal 37.2 (2011): 406-415. Web. 17 Feb. 2019.

V

  1. van den Heuvel, S.P.

    1. Gosselink, R. et al "Impact of inspiratory muscle training in patients with COPD: what is the evidence?." European Respiratory Journal 37.2 (2011): 416-425. Web. 17 Feb. 2019.

  2. van der Wal, W.M.

    1. Habraken, J.M. et al "Health-related quality of life and functional status in end-stage COPD: a longitudinal study." European Respiratory Journal 37.2 (2011): 280-288. Web. 17 Feb. 2019.

  3. Vanoirbeek, J.A.J.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  4. Verbeken, E.

    1. Hussain, S. et al "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model." European Respiratory Journal 37.2 (2011): 299-309. Web. 17 Feb. 2019.

  5. Vestbo, J.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  6. Villers, D.

    1. Darmon, M. et al "Procedure volume is one determinant of centre effect in mechanically ventilated patients." European Respiratory Journal 37.2 (2011): 364-370. Web. 17 Feb. 2019.

  7. Vittorakis, S.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  8. Vogelmeier, C.

    1. Kessler, R. et al "Symptom variability in patients with severe COPD: a pan-European cross-sectional study." European Respiratory Journal 37.2 (2011): 264-272. Web. 17 Feb. 2019.

W

  1. Wang, C-H.

    1. Liu, W-T. et al "A mobile telephone-based interactive self-care system improves asthma control." European Respiratory Journal 37.2 (2011): 310-317. Web. 17 Feb. 2019.

  2. Want, E.

    1. Izquierdo-García, J.L. et al "Is NMR-based metabolomic analysis of exhaled breath condensate accurate?." European Respiratory Journal 37.2 (2011): 468-470. Web. 17 Feb. 2019.

  3. Weersink, E.J.M.

    1. Habraken, J.M. et al "Health-related quality of life and functional status in end-stage COPD: a longitudinal study." European Respiratory Journal 37.2 (2011): 280-288. Web. 17 Feb. 2019.

  4. Wennergren, G.

    1. Lødrup Carlsen, K.C. et al "Assessment of problematic severe asthma in children." European Respiratory Journal 37.2 (2011): 432-440. Web. 17 Feb. 2019.

  5. Wiebel, M.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.

  6. Wouters, E.F.M.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

X

  1. Xanthou, G.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

Y

  1. Yew, W.W.

    1. Yew, W.W., C. Lange, and C.C. Leung. "Treatment of tuberculosis: update 2010." European Respiratory Journal 37.2 (2011): 441-462. Web. 17 Feb. 2019.

Z

  1. Zervas, E.

    1. Samitas, K. et al "Osteopontin expression and relation to disease severity in human asthma." European Respiratory Journal 37.2 (2011): 331-341. Web. 17 Feb. 2019.

  2. Zhu, G.

    1. Bakke, P.S. et al "Candidate genes for COPD in two large data sets." European Respiratory Journal 37.2 (2011): 255-263. Web. 17 Feb. 2019.

  3. Zimmerli, W.

    1. Schuetz, P. et al "Prognostic value of procalcitonin in community-acquired pneumonia." European Respiratory Journal 37.2 (2011): 384-392. Web. 17 Feb. 2019.

  4. Zugck, C.

    1. Schmitt, L. et al "Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma." European Respiratory Journal 37.2 (2011): 342-348. Web. 17 Feb. 2019.
Back to top
European Respiratory Journal: 37 (2)

Search Within This Issue

Jump to

Manage Table of content Alerts